New research - Bang et al - Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial
https://t.co/bRCpomv6lm
#GITwitter#Pancreatitis
@NEndoscopy@SahajRathi@Srisha_Hebbar Great read thanks John 👍 I think that 2/3 figure may hold up today if relying on scan report of reporting general radiologist, but if asking your ‘go to’ HPB radiologist today to report can’t believe it would be that high.
@NEndoscopy@SahajRathi@Srisha_Hebbar You may’ve already answered indirectly in that if operable you wouldn’t EUS but do brushings / SpyBite. I think Fluoro-guided endobiliary Bx can be done safely with excellent results. Gonna start reviewing a few years of data with SpR for our cases.
@NEndoscopy@SahajRathi@Srisha_Hebbar What’s the sensitivity without imaging evidence of significant soft tissue abnormality / mass / node on CT or MR John? Do you get a good pick up rate with FNB without above and just a bit a wall thickening when u do EUS?
@SahajRathi Do it as routine if imaging looks like primary ductal lesion. Keep GW in situ to guide re: line, needs adequate sphincterotomy, advance ~15mm out of scope then initial engagement of forceps into duct with scope manoeuvres only using endo and fluoro guidance to ensure good line.
Got asked to help out with a nice EMR this week. I've become a big fan of Tip-In EMR for certain polyps. Are you using it in your practice? What would have been your resection strategy of choice on this polyp? @BilalMohammadMD@EndoscopyOthman@RobertBechara@neilRsharmaMD
One of my favorite attendings from med school gave me advice that I still think about to this day. Over the past 5 years of residency, I've adjusted some items to be more applicable to a surgery resident so here is a 🧵of Dr. Touss' 5 rules of 💩 (w/ surgical modification) ...
Simple analogy of alcohol liver disease vs hepatitis C:
- Not detecting alcohol underreporting is like using a HVC test with many false negatives.
- Not treating underlying alcohol use disorder, it’s like denying antivirals to HCV patients.
#livertwitter#MedTwitter@EASLedu
OPTIMAL-IPMN officially up n’ running!
We need to stop resecting IPMN with low grade dysplasia.
Can we push time-point for resection?
Join us to find predictors for resection or surveillance!
https://t.co/mDRu2OAFBO
@poyaghorbani@HpbKarolinska@EAHPBA
Risk of main duct dilatation in mixed-type IPMN 🌿 in @AGA_CGH
Risk of cancer at 2 and 5 years:
⚠️ 5-9 mm ➡️ 8% and 10%
🚨 > 10 mm ➡️ 16% and 33%
🔥 Hot topic at @EurPancClub 2023 and for the upcoming guidelines !!!
https://t.co/RxwgiQPFEc